https://www.selleckchem.com/pr....oducts/l-histidine-m
Thirty-day mortality was 8%, 7%, and 9% in groups 1, 2, and 3, respectively. There were no differences in safety outcomes between antibiotic regimens. After adjusting for treatment group and gestational age, mortality rates through end of follow-up were 4.22 [95% confidence interval (CI) 1.39-12.13], 4.53 (95% CI 1.21-15.5, and 4.07 (95% CI 1.22-12.7 for groups 1, 2, and 3, respectively. Each of the antibiotic regimens are safe in premature infants with cIAI. NCT0199499. NCT0199499. Cytomegalovirus
Curtir
Comentario
Compartilhar
